The Effectiveness of EMDR Therapy as a Trauma-Focused Intervention for Reducing the Severity of PTSD Symptoms in Jordan: A Quasi-Experimental Trial
Experimental
2 other identifiers
interventional
70
1 country
1
Brief Summary
Here is a plain-language, registry-appropriate Brief Summary you can paste into the form. It is written for patients, families, and healthcare providers: Brief Summary This study examines whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can reduce the severity of symptoms in adults experiencing post-traumatic stress disorder (PTSD) in Jordan. PTSD can develop after exposure to distressing or traumatic life events and may cause symptoms such as intrusive memories, avoidance, sleep problems, anxiety, and emotional distress. A total of 70 adult participants with moderate to severe PTSD symptoms were enrolled. Participants were assigned to one of two groups: an EMDR therapy group or a waitlist control group. Individuals in the EMDR group received structured therapy sessions delivered by a trained mental-health professional, while those in the waitlist group did not receive therapy during the study period but were offered treatment after the study ended. PTSD symptom severity was measured before treatment, immediately after the therapy sessions, and again one month later. The goal of the study was to determine whether EMDR therapy leads to meaningful and lasting reductions in PTSD symptoms compared with no immediate treatment. The findings of this research are intended to help healthcare providers and policymakers understand the value of EMDR as a non-pharmacological, evidence-based treatment option for individuals experiencing trauma-related distress, and to support improvements in mental-health services and trauma-informed care in Jordan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2024
CompletedFirst Submitted
Initial submission to the registry
February 14, 2026
CompletedFirst Posted
Study publicly available on registry
February 20, 2026
CompletedFebruary 20, 2026
February 1, 2026
10 months
February 14, 2026
February 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severity of post-traumatic stress symptoms
Severity of post-traumatic stress symptoms measured using the Primary Care Post-Traumatic Stress Disorder Screen (PC-PTSD) questionnaire at baseline (T0), immediately post-intervention (T1), and one-month follow-up (T2).
Baseline, immediately after intervention, and 1-month follow-up.
Study Arms (2)
EMDR Therapy Intervention
EXPERIMENTALParticipants in this arm received Eye Movement Desensitization and Reprocessing (EMDR) therapy delivered by a licensed psychiatric mental-health professional trained in the standardized EMDR protocol. The intervention consisted of structured individual sessions (approximately 90 minutes each) conducted over several weeks. Sessions followed the established EMDR phases, including history taking, preparation, desensitization with bilateral stimulation, installation of positive cognitions, body scan, closure, and reevaluation. Outcomes were assessed at baseline, immediately post-intervention, and at one-month follow-up.
Waitlist Control
NO INTERVENTIONParticipants in this arm did not receive active psychological intervention during the study period and continued with usual care, if any. They completed the same outcome assessments at baseline, immediately after the intervention period for the EMDR group, and at one-month follow-up. After completion of all study assessments, participants in the waitlist control arm were offered the opportunity to receive EMDR therapy.
Interventions
Participants received Eye Movement Desensitization and Reprocessing (EMDR) therapy, a structured trauma-focused psychotherapy delivered individually by a licensed psychiatric mental-health professional trained in the standardized EMDR protocol. Sessions lasted approximately 90 minutes and were conducted three times per week over the intervention period. The protocol followed the established EMDR phases, including history taking, preparation, identification of target memories, bilateral stimulation (e.g., guided eye movements or alternating taps), installation of adaptive cognitions, body scan, closure, and reevaluation. Outcomes were measured at baseline, immediately post-intervention, and at one-month follow-up.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- Probable PTSD or moderate-to-severe post-traumatic stress symptoms based on the screening instrument used in the study
- Exposure to at least one traumatic or highly stressful life event within the previous six months
- No prior receipt of EMDR therapy
- Willingness and ability to provide informed consent and participate in therapy sessions and assessments
You may not qualify if:
- Acute cognitive or intellectual disability that would interfere with comprehension of study procedures or questionnaires
- Significant visual impairment or visual pathology that would prevent full engagement with the visual components of EMDR therapy
- Inability to communicate effectively by phone for scheduled assessments
- Refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Nursing
Amman, Aljubeiha, 11942, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayman M. Hamdan-Mansour, Professor
The University of Jordan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking was implemented. Participants, intervention providers, and outcome assessors were aware of group allocation throughout the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assisstant professor
Study Record Dates
First Submitted
February 14, 2026
First Posted
February 20, 2026
Study Start
March 15, 2023
Primary Completion
December 25, 2023
Study Completion
February 14, 2024
Last Updated
February 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to privacy, confidentiality, and ethical considerations related to the sensitive mental-health information collected. Data may be made available in a de-identified and aggregated form upon reasonable request to the corresponding author and subject to institutional ethics approval and data-use agreements.